Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2821 AL 2835

Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders

Domínguez-Fernández C, Egiguren-Ortiz J, Razquin J, Gómez-Galán M, De Las Heras-García L, Paredes-Rodríguez E, Astigarraga E, Miguélez C, Barreda-Gómez G.

Int J Mol Sci. 2023 Feb 7;24(4):3321. doi: 10.3390/ijms24043321.

Disease-modifying vs symptomatic treatments: Splitting over lumping

Duque KR, Vizcarra JA, Hill EJ, Espay AJ.

Handb Clin Neurol. 2023;193:187-209. doi: 10.1016/B978-0-323-85555-6.00020-5.

[Treatment-Quo vadis neurodegeneration?]

Vöglein J, Levin J, Höglinger G.

Nervenarzt. 2023 Oct;94(10):904-912. doi: 10.1007/s00115-023-01544-x. Epub 2023 Oct 6.

Blood Neurofilament Light Chain in Different Types of Dementia

Gu L, Shu H, Wang Y, Wang P.

Curr Alzheimer Res. 2023;20(3):149-160. doi: 10.2174/1567205020666230601123123.

Lipids as Emerging Biomarkers in Neurodegenerative Diseases

Wei J, Wong LC, Boland S.

Int J Mol Sci. 2023 Dec 21;25(1):131. doi: 10.3390/ijms25010131.

Molecularly imprinted polymers for the recognition of biomarkers of certain neurodegenerative diseases

Pilvenyte G, Ratautaite V, Boguzaite R, Samukaite-Bubniene U, Plausinaitis D, Ramanaviciene A, Bechelany M, Ramanavicius A.

J Pharm Biomed Anal. 2023 May 10;228:115343. doi: 10.1016/j.jpba.2023.115343. Epub 2023 Mar 14.

Fluid and Biopsy Based Biomarkers in Parkinson's Disease

Coughlin DG, Irwin DJ.

Neurotherapeutics. 2023 Jul;20(4):932-954. doi: 10.1007/s13311-023-01379-z. Epub 2023 May 3.

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease

Herden JM, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, Nuhn S, Volpers C, Schlung A, Goebel S, Kück F, Villar-Piqué A, Schmidt C, Wedekind D, Zerr I.

Alzheimers Res Ther. 2023 Jun 8;15(1):106. doi: 10.1186/s13195-023-01249-y.

Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review

Nicoletti A, Baschi R, Cicero CE, Iacono S, Re VL, Luca A, Schirò G, Monastero R; Gender Neurology Study Group of the Italian Society of Neurology.

Mech Ageing Dev. 2023 Jun;212:111821. doi: 10.1016/j.mad.2023.111821. Epub 2023 Apr 29.

Genome-Wide Meta-Analysis of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Parkinson's Disease Cohorts

Ta M, Blauwendraat C, Antar T, Leonard HL, Singleton AB, Nalls MA, Iwaki H; Alzheimer's Disease Neuroimaging Initiative (ADNI); and the Fox Investigation for New Discovery of Biomarkers.

Mov Disord. 2023 Sep;38(9):1697-1705. doi: 10.1002/mds.29511. Epub 2023 Aug 4.

Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients

Fang C, Hernandez P, Liow K, Damiano E, Zetterberg H, Blennow K, Feng D, Chen M, Maccecchini M.

J Prev Alzheimers Dis. 2023;10(1):25-33. doi: 10.14283/jpad.2022.84.

The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target

Jaberi KR, Alamdari-Palangi V, Jaberi AR, Esmaeli Z, Shakeri A, Gheibi Hayat SM, Tajbakhsh A, Savardashtaki A.

Curr Mol Med. 2023;23(9):863-875. doi: 10.2174/1566524023666220817145638.

Exosomes for the diagnosis and treatment of dementia

Joo HS, Jeon HY, Hong EB, Kim HY, Lee JM.

Curr Opin Psychiatry. 2023 Mar 1;36(2):119-125. doi: 10.1097/YCO.0000000000000842. Epub 2023 Jan 11.

Tau: a biomarker of Huntington's disease

Lepinay E, Cicchetti F.

Mol Psychiatry. 2023 Oct;28(10):4070-4083. doi: 10.1038/s41380-023-02230-9. Epub 2023 Sep 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias